GM Food Debate Gets Spicy

Whether sitting down to a relaxing dinner or grabbing fast food, people don't think about the origin of every ingredient in the food they eat. But as biotechnology applications in commercial agriculture increase, controversy over the risks versus the benefits also continues to rise. In mid-September, public citizen groups, including Genetically Engineered Food Alert and the Union of Concerned Scientists, requested a recall of taco shells that allegedly contained genetically engineered corn. Inde

Written byKate Devine
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Whether sitting down to a relaxing dinner or grabbing fast food, people don't think about the origin of every ingredient in the food they eat. But as biotechnology applications in commercial agriculture increase, controversy over the risks versus the benefits also continues to rise. In mid-September, public citizen groups, including Genetically Engineered Food Alert and the Union of Concerned Scientists, requested a recall of taco shells that allegedly contained genetically engineered corn. Independent testing by Kraft Foods Inc. confirmed that flour from genetically altered corn containing a Bacillus thuringiensis (Bt) gene was used in a Mexican taco shell plant and a recall was initiated. The Bt gene produces a protein toxic to certain insects and the corn is currently not government-approved for human consumption due to an allergic-response potential.

Citizen groups claim that this incident is an example of the flaws in the current regulatory system for genetically engineered food. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies